We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01444807
Recruitment Status : Recruiting
First Posted : October 3, 2011
Last Update Posted : March 22, 2017
Sponsor:
Information provided by (Responsible Party):
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Primary Completion Date : March 2017
  Estimated Study Completion Date : September 2019